Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STEEL-PCI: Ticagrelor vs Clopidogrel in Stable CAD PCI
NCT02327624Phase 4Completed
- Sponsor
- Sheffield Teaching Hospitals NHS Foundation Trust
- Start
- Jun 2015
- Primary completion
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ticagrelor in coronary artery disease (CAD), sponsored by Sheffield Teaching Hospitals NHS Foundation Trust. Started Jun 2015; status: completed.
02
Drugs
ticagrelor
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT02327624.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02327624.